Mirum Pharmaceuticals MIRM reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Mirum Pharmaceuticals beat estimated earnings by 26.96%, reporting an EPS of $-0.84 versus an estimate of $-1.15.
Revenue was up $6.48 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 0.92% increase in the share price the next day.
Here's a look at Mirum Pharmaceuticals's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.34 | 0.34 | -1.73 | |
| EPS Actual | -1.17 | -1.65 | -1.55 | -1.45 |
| Revenue Estimate | 8.46M | 62.65M | 830K | 14.50M |
| Revenue Actual | 12.89M | 3.14M | 5.00M | 11.00M |
To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
